PainchekASX:PCK +4.17% PS Ratio is 5.56 as of Jun. 29, 2026, which is 82% below its 10-year median of 31.73. The stock has 3 warning signs investors should review. Among 657 Healthcare Providers & Services companies, Painchek ranks worse than 83.11% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Painchek's share price is A$0.10.
Painchek's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.02. Hence, Painchek's PS Ratio for today is 5.56.
Good Sign:
Painchek Ltd stock PS Ratio (=5.26) is close to 10-year low of 5.26.
The historical rank and industry rank for Painchek's PS Ratio or its related term are showing as below:
ASX:PCK'
s PS Ratio Range Over the Past 10 Years
Min: 5.26 Med: 31.73 Max: 1619.55
Current: 5.56
During the past 13 years, Painchek's highest PS Ratio was 1619.55. The lowest was 5.26. And the median was 31.73.
ASX:PCK's PS Ratio is ranked worse than 83.11% of 657
companies
in the Healthcare Providers & Services industry
Industry Median: 1.51
vs ASX:PCK: 5.56
Painchek Ltd revenue growth has slowed down over the past 12 months.
During the past 3 years, the average Revenue per Share Growth Rate was 28.30% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 69.00% per year.
During the past 13 years, Painchek's highest 3-Year average Revenue per Share Growth Rate was 108.00% per year. The lowest was 28.30% per year. And the median was 80.40% per year.
Back to Basics: PS Ratio
Painchek (ASX:PCK) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Painchek PS Ratio Related Terms
Painchek PS Ratio Historical Data
* Premium members only.
The historical data trend for Painchek's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Painchek's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Painchek PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Painchek's PS Ratio distribution charts can be found below:
* The bar in red indicates where Painchek's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Painchek's Share Price of today is A$0.10.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Painchek's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.02.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Painchek (ASX:PCK) has a PS Ratio of 5.56 as of Jun. 29, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Painchek and its competitors. This is 82% below median its historical median of 31.73. Over the past decade, Painchek's PS Ratio has ranged from 5.26 to 1,619.55. According to the industry distribution chart, Painchek ranks #546 out of 657 companies in the Healthcare Providers & Services industry, placing it in the top 83.1%.
Is Painchek's PS Ratio too high?
Painchek's current PS Ratio of 5.56 is 82% below median its 10-year median of 31.73. Over the past 10 years, this metric has ranged from a low of 5.26 to a high of 1,619.55. The Healthcare Providers & Services industry median PS Ratio is 1.51. Painchek's value of 5.56 is 268.2% above this industry median. Based on the distribution chart, Painchek ranks #546 out of 657 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does Painchek's PS Ratio compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Painchek ranks #546 out of 657 companies for PS Ratio. This places Painchek in the lower half of its industry. The industry median PS Ratio is 1.51. Painchek's value of 5.56 is 268.2% above this benchmark. Historically, Painchek's own PS Ratio has ranged from 5.26 to 1,619.55 over the past decade. While the company's 10-year median is 31.73 vs. the industry median of 1.51, Painchek has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Healthcare Providers & Services company?
The median PS Ratio among Healthcare Providers & Services companies is 1.51, based on 657 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Painchek's current PS Ratio of 5.56 is 268.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Painchek and its competitors. For the Healthcare Providers & Services industry, the median PS Ratio is 1.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Painchek's current PS Ratio is 5.56, which is 82% below median its own 10-year median of 31.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Painchek stock overvalued right now?
Based on GuruFocus' analysis, Painchek (ASX:PCK) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.40, compared to a current price of A$0.10 — trading 75% below its estimated fair value. The current PS Ratio is 5.56, which is 82% below median its 10-year median of 31.73 and 268.2% above the Healthcare Providers & Services industry median of 1.51. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Painchek (ASX:PCK), the current PS Ratio is 5.56 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Painchek Ltd is engaged in the development and commercialization of mobile medical device applications that provide pain assessment for individuals who are unable to communicate pain with carers. It operates in one segment, namely the sale of its pain assessment solutions. Its geographic segments include Australia, the United Kingdom, and Other countries, of which it generates the majority of its revenue from Australia.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:PCK has been successfully added to your 